Apoptosis

, Volume 18, Issue 1, pp 110–120

p53 acetylation enhances Taxol-induced apoptosis in human cancer cells

  • Jae Hyeong Kim
  • Eun-Kyung Yoon
  • Hye-Jin Chung
  • Seong-Yeol Park
  • Kyeong-Man Hong
  • Chang-Hun Lee
  • Yeon-Su Lee
  • Kyungho Choi
  • Young Yang
  • Kyungtae Kim
  • In-Hoo Kim
Original Paper

DOI: 10.1007/s10495-012-0772-8

Cite this article as:
Kim, J.H., Yoon, EK., Chung, HJ. et al. Apoptosis (2013) 18: 110. doi:10.1007/s10495-012-0772-8

Abstract

Microtubule inhibitors (MTIs) such as Taxol have been used for treating various malignant tumors. Although MTIs have been known to induce cell death through mitotic arrest, other mechanisms can operate in MTI-induced cell death. Especially, the role of p53 in this process has been controversial for a long time. Here we investigated the function of p53 in Taxol-induced apoptosis using p53 wild type and p53 null cancer cell lines. p53 was upregulated upon Taxol treatment in p53 wild type cells and deletion of p53 diminished Taxol-induced apoptosis. p53 target proteins including MDM2, p21, BAX, and β-isoform of PUMA were also upregulated by Taxol in p53 wild type cells. Conversely, when the wild type p53 was re-introduced into two different p53 null cancer cell lines, Taxol-induced apoptosis was enhanced. Among post-translational modifications that affect p53 stability and function, p53 acetylation, rather than phosphorylation, increased significantly in Taxol-treated cells. When acetylation was enhanced by anti-Sirt1 siRNA or an HDAC inhibitor, Taxol-induced apoptosis was enhanced, which was not observed in p53 null cells. When an acetylation-defective mutant of p53 was re-introduced to p53 null cells, apoptosis was partially reduced compared to the re-introduction of the wild type p53. Thus, p53 plays a pro-apoptotic role in Taxol-induced apoptosis and acetylation of p53 contributes to this pro-apoptotic function in response to Taxol in several human cancer cell lines, suggesting that enhancing acetylation of p53 could have potential implication for increasing the sensitivity of cancer cells to Taxol.

Keywords

Taxolp53ApoptosisAcetylationSirt1HDAC inhibitor

Supplementary material

10495_2012_772_MOESM1_ESM.tif (29.3 mb)
Supplementary material 1 (TIFF 29986 kb)
10495_2012_772_MOESM2_ESM.tif (209.3 mb)
Supplementary material 2 (TIFF 214362 kb)
10495_2012_772_MOESM3_ESM.tif (29.3 mb)
Supplementary material 3 (TIFF 30046 kb)

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Jae Hyeong Kim
    • 1
    • 2
  • Eun-Kyung Yoon
    • 1
    • 3
  • Hye-Jin Chung
    • 1
  • Seong-Yeol Park
    • 1
  • Kyeong-Man Hong
    • 1
  • Chang-Hun Lee
    • 1
  • Yeon-Su Lee
    • 1
  • Kyungho Choi
    • 1
    • 4
  • Young Yang
    • 2
  • Kyungtae Kim
    • 1
  • In-Hoo Kim
    • 1
  1. 1.Research Institute National Cancer CenterIlsandon-gu, Goyang-siKorea
  2. 2.Department of Life ScienceResearch Center for Woman’s Disease, Sookmyung Woman’s UniversitySeoulKorea
  3. 3.Division of Life and Phamaceutical Sciences, The graduate SchoolEwha Womans UniversitySeodaemun-gu, SeoulKorea
  4. 4.Department of Biochemistry and Molecular BiologySeoul National University college of MedicineJongno-gu, SeoulKorea